Mylan Laboratories Inc. Selects ValueCentric to Monitor Expanding Generics Product Portfolio, Streamline Sales and Marketing Analytics Capabilities

ORCHARD PARK, NY--(MARKET WIRE)--Jun 12, 2007 -- ValueCentric, LLC®, the leading provider of on-demand data management and performance analytics to the pharmaceutical industry, today announced that Mylan Laboratories Inc. has selected the company’s award-winning ValueTrak® solution to monitor sales activity and order patterns as well as analyze chargebacks and returns for its extensive line of more than 500 products. A global pharmaceutical company, Mylan holds market-leading positions in generic pharmaceuticals, transdermal technology and unit dose packaged products, with an extensive line of affordable, high quality prescription drugs in traditional and innovative dosage forms.

MORE ON THIS TOPIC